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Adopting three physically-motivated scales (“micro” – “meso” – “macro”, which refer to
mpc – kpc – Mpc, respectively) is paramount for achieving a unified theory of multiphase
active galactic nuclei feeding and feedback, and it represents a keystone for astrophysical
simulations and observations in the upcoming years. In order to promote this multi-scale
idea, we have decided to adopt an interdisciplinary approach, exploring the possible
conceptual similarities between supermassive black hole feeding and feedback cycles
and the dynamics occurring in human cancer microenvironment.
Keywords: cancer microenvironment, exosomes, metastasis, multi-scale feeding and feedback cycles,
supermassive black holesINTRODUCTION
Several scientific problems show complexities that can be understood only through a multi-scale
approach, in which apparently disjointed processes are linked together across multiple scales. One
of such examples is the astrophysical study of supermassive black holes (SMBHs), which resides at
the core of virtually every galaxy in the universe. Feeding of matter from galactic distances onto
SMBHs is thought to be the physical process powering active galactic nuclei (AGN), which are
observed up to extremely large distances due to their large luminosities and are supposed to impact
the evolution of their host galaxies through mechanical feedback from winds and jets (1–3).
It is important to remind that the typical scale associated with a SMBH is in units of its
Schwarzschild radius rs = 2GMBH/c
2, where G is the gravitational constant, c is the speed of light,
and MBH is the mass of the SMBH. For a value of the SMBH mass of ≃ 1010 times that of our Sun,
this corresponds to a scale in units of parsec of 1 mpc = 10−3pc ≃ 1014 ° cm. This scale is larger than
the distance between our Earth and the Sun, but it is negligible when compared to the size of a
typical galaxy that can span a radius of more than 10 kpc. Therefore, the study of AGN and their
host galaxies is inherently a multi-scale problem.May 2021 | Volume 11 | Article 6348181
Santoni et al. Black Holes and Cancer MicroenvironmentIt has been recently assessed that adopting three physically-
motivated scales (“micro” – “meso –macro, which refer tompc –
kpc – Mpc, respectively) is paramount for achieving a unified
theory of multiphase AGN feeding and feedback, and it represents
keystone for astrophysical simulations and observations in the
upcoming years (4). In order to promote this multi-scale idea, we
have decided to adopt an interdisciplinary approach, exploring the
possible conceptual similarities between SMBH feeding and
feedback cycles and the dynamics occurring in human
cancer microenvironment.
To this end, analogously to the three major scales (“micro”,
“meso” and “macro”) identified in the aforementioned
astrophysical investigation, we defined three distinct scales
within the tumor microenvironment: (1) micro ≡intratumor
network; (2) meso≡ intercellular exchanges between tumor
and immune cells; and (3) macro ≡extracellular vesicles-based
communication between primary tumor and distant pre-
metastatic niches. In these three contexts, cell-to-cellFrontiers in Oncology | www.frontiersin.org 2communication is mediated by exosomes, nano-sized vesicles
(40-100 nm in diameter) enclosed by a lipid bilayer and released
by cells under healthy or pathological conditions (5) (Figure 1).
Exosomes contain a variety of biomolecules that include
oncogenic proteins, signaling molecules, glycans, lipids,
metabolites, RNA, and DNA (6).MICRO: EXOSOME-BASED INTRATUMOR
COMMUNICATION
Studies focused on a variety of distinct cancer cells reported
that tumor-derived exosomes can promote tumor cell
proliferation. An autocrine induction of cellular proliferation
was reported in chronic myeloid leukemia (7), gastric cancer (8),
bladder cancer (9), glioblastoma (10) and melanoma (11).
Furthermore, exosomes-based intratumor communication is
also fundamental for the acquisition of migratory properties inFIGURE 1 | Fluorescence image of HEK293T cells in culture. The clear areas indicate a high concentration of exosomes. These cells were engineered to produce
exosomes containing the GFP fluorescent protein.May 2021 | Volume 11 | Article 634818
Santoni et al. Black Holes and Cancer Microenvironmentcancer cells from the primary tumor. This phenomenon has been
reported in both nasopharyngeal carcinoma (12) and prostate
cancer (13), where exosomes released by primary tumor cells can
increase the invasiveness and motility of other recipient
malignant cells (Figure 2).
A single cancer cell can produce and release in the blood from
2000 to 7000 exosomes (14). In 2018, Professor Avner Friedman
and Professor Wenrui Hao (15) developed a mathematical model
that resumes the production of tumor exosomes and the release











where Ec identifies the exosomes produced by cancer cell over
time, t = time, DEcis the diffusion coefficient of EC, lEc is the
production rate of Ec, C means Cancer cell density and Kc
indicates cancer cell saturation.
Exosomes released by tumor cells provide a paracrine
signaling mechanism for cancer progression. Exosomes contain
microRNAs (miRNAs), lipids and proteins that are cell type
specific. The secretion and delivery of exosomal miRNAs are the
basis for cancer cell-to-cell communication and contribute as
signaling molecules to the creation of a tumor-promoting
environment (16). The transfer of exosomal miRNAs can
confer also acquired drug resistance by encoding proteins that
can lead to chemoresistance in the recipient tumor cells (17).Frontiers in Oncology | www.frontiersin.org 3miR-21 is one of the most studied (18) and enhances tumor
growth when is released by exosomes through the encounter
between Ec and cancer cells, as expressed by the equation (15):
∂miR21
∂ t
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⎵
degradation
where DmiR-21 is the diffusion coefficient of miR21once released
by exosomes, estimated at 0.130 cm2/day (19), lmiR21Ec
represents the production rate of miR-21 by Ec, Kc indicates
cancer cell saturation (estimated at 0.4 g/cm3) (20) and dmiR21the
degradation rate of miR-21.MESO: EXOSOME-BASED DIALOGUE
BETWEEN TUMOR AND IMMUNE CELLS
The ability to develop strategies to escape from host immune
surveillance is one of the hallmarks of cancer (21). It has been
shown that tumor-derived exosomes can down-regulate CD3z
and Janus kinase 3 (JAK3) expression in primary activated T-
cells, mediate the apoptosis of CD8+ T-cells and the conversion
of CD4+ CD25- T-cell into CD4+CD25(hi)FOXP3+regulatory






FIGURE 2 | A diagram of the feeding and feedback cycles, showing the geometric increase of three orders of magnitude (micro, meso and macro) in tumor
microenvironment. Tumor-derived exosomes can increase the invasiveness and motility of recipient cells. This exosome-mediated communication occurs at three
different levels: between cancer cells in the primary tumor (micro), between cancer and immune cells (meso) and between cancer cells from the primary tumor to the
metastatic sites (macro).May 2021 | Volume 11 | Article 634818
Santoni et al. Black Holes and Cancer Microenvironmentfactor b1 and cytotoxic T-lymphocyte antigen 4 that effectively
mediate suppression) (22) (Figure 2).
Ec produced by tumor cells release their content through the
encounter with a variety of immune cells including Th1 cells
(T4), CD8+ cells (T8), regulatory T cells (Tr) and dendritic cells
(D):

















where T4, T8,Tr and D express different immune cell density,
while K indicate cell saturation estimated at 2 x 10−3 g/ml for T4
and T8, 5 x 10
−4 g/ml for Tr (20, 23) and 4 x 10
−6 g/cm3 for D
(24–26). The complex interactions of T8,D and tumor cells (T)
within the tumor has been described by Depillis and colleagues
(27), who extended the model previously elaborated by Ludewig
et al. (28) by adding a tumor compartment. In particular, they
took into account tumor-immune system parameters such as
immune cell trafficking rates to and from the tumor, effector cell
deactivation rates by tumor cells, effector cell death rates,
intrinsic tumor growth rates, and tumor cell kill rates by












Interactions   between  CD8+and   tumor   cells
where Eatumor is the number of CD8
+ cells within the tumor, T is
the number of tumor cells, mBTE is the T-dependent rate at which
effector cells enter the tumor compartment from the blood, Eablood
is the number of CD8+ cells in the blood, a EaT is the death rate of
activated CD8+ in the tumor [estimated at 0.462/day (29)], c is
the rate at which activated CD8+ are inactivated by T [estimated
at 9.42 x 10-12 cells x day (27)];
d
dt














Tumor   growth   and   lysis   by  CD8+
where r is the tumor growth rate [estimated at 0.3954/day (30)], k
is the carrying capacity of tumor [estimated at 1.0 x 109 cells
(30)] s is the value of E
a
tumor
T necessary for half-maximal activated
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⎵
Interations   between   tumor   and   dendritic   cells
where Dtumor is the number of tumor-infiltrating dendritic cells,
m is the maximum recruitment rate of DCs to tumor site
[estimated at 2.4388 x 104 cells/day (27)], q is the value of T
necessary for half-maximal DC recruitment [estimated at 100
cells (27)], mTB is the rate of dendritic cell transfer from tumor toFrontiers in Oncology | www.frontiersin.org 4blood [estimated at 0.0011/day (27)], and aD is the natural death
rate of dendritic cells [0.2310/day (28)].MACRO: EXOSOME-BASED
COMMUNICATION BETWEEN PRIMARY
TUMOR AND METASTASES
As reported above, tumor-derived exosomes promotes the
invasiveness and motility of tumor cells from the primary site
to metastatic niches (12, 13) (Figure 2). By analyzing different
cell lines, Yu et al. (31) observed 79 proteins that were differently
expressed in exosomes between more and less metastatic tumors,
and these proteins were implicated in cell adhesion, invasion,
growth, metabolism and metastasis (31). Tumor-derived
exosomes are crucial for the formation of pre-metastatic niches
(32), which are necessary for the creation of a suitable
environment for circulating tumor cells (CTCs) colonization
and growing within a secondary site (33). The choice of
metastatic sites is orchestrated by the primary tumor through
secreted factors, with exosomes representing the main
extravescicular population that mediates long-range signaling
during metastasis (34–36). Exosome proteomics revealed distinct
integrin expression patterns that could be used to predict organ-
specific metastasis (37). For example, exosomalintegrinsa6b4
and a6b1 were linked to lung metastases, while avb5
was associated to liver metastases (37), supporting the
organotropism of tumor-derived exosomes.
If we assume that the production of tumor exosomes Ec and












We can derive that the diffusion of tumor-derived exosomes











Diffusion   of   exosomes   from   primary   tumor   to  metastastic   cells
Where lEc is the production rate of Ec and Kc indicates cancer
cell saturation.
The diffusion of tumor-derived exosomes (DEc) from the
primary tumor the pre-metastatic niche can be estimated
through considering the average diameters of exosomes
(70 nm) at1.23 x 10-4 cm2/day (15). The release of Ec promotes
the initial phases of tumor invasion and metastatization,
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Santoni et al. Black Holes and Cancer Microenvironmentwhere Dc is the diffusion coefficient of cancer cells, c∇ (C ∇C)
indicates the migration of cancer cells, lC the growth rate due
respectively to driver signalling pathways 1 (SP1) and 2 (SP2), CM
the carrying capacity of tumor cellsand dDC and dcC account,
respectively, for the rate of damage-induced or natural apoptotic
cancer cells.CONCLUSIONS
Analogies between multi-scale feeding and feedback cycles in
supermassive black hole and cancer environments can allow the
crossover of mathematical models between these two fields.
Nevertheless, our model should be validated. The recent
advances in tissue biology on several spatial scales including
multi-cellular, single cell and the sub-cellular levels will expand
our comprehension of the mechanisms of exosome-mediated
communication and will allow us to measure the distances
needed for cell-to-cell interactions. In this context, Nanostring
technology can be employed to investigate tumor spatial andFrontiers in Oncology | www.frontiersin.org 5time heterogeneity. The potential consequences of the creation
and validation of this model on the exosome-mediated
communication between tumor cells and immune cells will be
both clinical and therapeutical. Indeed, modelling exosome-
mediated communication may allow to predict the time to
metastases, to avoid tumor-induced immunosuppression and
to develop exosomes for targeted delivery drug.
A straight cooperation and merging of such apparently
distant disciplines may result a turning point to exceed the
current limits of astrophysical and oncological modelling
procedures in future years.AUTHOR CONTRIBUTIONS
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